PERRIGO Co plc (PRGO) stock
PRGONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3028% below fair value
$16.94+1.18 (+7.49%)
Close on Nov 18, 2026Market cap $2.35BP/E –Yield 6.85%
Perrigo shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Perrigo's shares outstanding was 140M at Jun 27, 2026. For fiscal 2025 it was 139M, up 0.8% from the year before. Over ten years it grew 1.8% a year on average. The highest annual figure on record is 143M in fiscal 2017.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 139M | +0.8% |
| FY2024 | Dec 31, 2024 | 137M | +1.6% |
| FY2023 | Dec 31, 2023 | 135M | +0.6% |
| FY2022 | Dec 31, 2022 | 135M | +0.7% |
| FY2021 | Dec 31, 2021 | 134M | -2.6% |
| FY2020 | Dec 31, 2020 | 137M | +0.5% |
| FY2019 | Dec 31, 2019 | 137M | -1.3% |
| FY2018 | Dec 31, 2018 | 138M | -3.0% |
| FY2017 | Dec 31, 2017 | 143M | +2.0% |
| FY2015 | Jun 27, 2015 | 140M | +20.9% |
| FY2014 | Jun 28, 2014 | 116M | +22.3% |
| FY2013 | Jun 29, 2013 | 95M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 27, 2026 | 140M | +1.0% |
| Q1 FY2026CQ1 2026 | Mar 28, 2026 | 139M | +0.7% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | 138M | -0.1% |
| Q3 FY2025CQ3 2025 | Sep 27, 2025 | 139M | +1.0% |
| Q2 FY2025CQ2 2025 | Jun 28, 2025 | 138M | +0.8% |
| Q1 FY2025CQ1 2025 | Mar 29, 2025 | 138M | +0.1% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | 138M | +4.8% |
| Q3 FY2024CQ3 2024 | Sep 28, 2024 | 138M | +0.4% |
| Q2 FY2024CQ2 2024 | Jun 29, 2024 | 137M | +0.4% |
| Q1 FY2024CQ1 2024 | Mar 30, 2024 | 138M | +2.0% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | 131M | -2.5% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | 137M | +1.7% |
| Q2 FY2023CQ2 2023 | Jul 1, 2023 | 137M | +1.5% |
| Q1 FY2023CQ1 2023 | Apr 1, 2023 | 135M | +0.7% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | 135M | +0.7% |
| Q3 FY2022CQ3 2022 | Oct 1, 2022 | 135M | +0.6% |
| Q2 FY2022CQ2 2022 | Jul 2, 2022 | 135M | +0.7% |
| Q1 FY2022CQ1 2022 | Apr 2, 2022 | 134M | -0.4% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | 134M | -1.1% |
| Q3 FY2021CQ3 2021 | Oct 2, 2021 | 134M | -2.8% |
| Q2 FY2021CQ2 2021 | Jul 3, 2021 | 134M | -2.8% |
| Q1 FY2021CQ1 2021 | Apr 3, 2021 | 135M | -2.0% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | 135M | -1.2% |
| Q3 FY2020CQ3 2020 | Sep 26, 2020 | 138M | +0.6% |
| Q2 FY2020CQ2 2020 | Jun 27, 2020 | 138M | +0.7% |
| Q1 FY2020CQ1 2020 | Mar 28, 2020 | 137M | +0.8% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | 137M | +0.5% |
| Q3 FY2019CQ3 2019 | Sep 28, 2019 | 137M | -0.4% |
| Q2 FY2019CQ2 2019 | Jun 29, 2019 | 137M | -1.6% |
| Q1 FY2019CQ1 2019 | Mar 30, 2019 | 136M | -3.7% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | 136M | -3.5% |
| Q3 FY2018CQ3 2018 | Sep 29, 2018 | 137M | -3.0% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | 139M | -3.2% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | 141M | -1.5% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | 141M | -3.5% |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | 142M | +0.6% |
| Q2 FY2017CQ2 2017 | Jul 1, 2017 | 143M | – |
| Q1 FY2017CQ1 2017 | Apr 1, 2017 | 144M | – |
| Q4 FY2015CQ2 2015 | Jun 27, 2015 | 146M | – |
| Q3 FY2015CQ1 2015 | Mar 28, 2015 | 141M | – |
See a number that looks wrong?